Last update Feb. 7, 2025
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Flufenamic Acid in other languages or writings:
Flufenamic Acid belongs to this group or family:
Main tradenames from several countries containing Flufenamic Acid in its composition:
| Variable | Value | Unit |
|---|---|---|
| Molecular weight | 281 | daltons |
| VD | > 0.5 | l/Kg |
| pKa | 3.88 | - |
| Tmax | 1.5 | hours |
| T½ | 5 - 22 | hours |
| M/P ratio | 0.01 | - |
| Theoretical Dose | 0.008 | mg/Kg/d |
| Relative Dose | 0.08 | % |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Nonsteroidal anti-inflammatory drug for topical use related to mefenamic acid. Precursor of etofenamate. Oral forms of administration are also available.
Excreted in breast milk in negligible, clinically insignificant amount, even after oral administration. The milk/plasma ratio is 0.01.(Buchanan 1969)
The small dose and poor plasma absorption of most topical dermatological preparations make passage of significant amount into blood plasma and even less into breast milk unlikely.
American Academy of Pediatrics: medication usually compatible with breastfeeding. (AAP 2001)
See below the information of this related product: